Skip to main content
Premium Trial:

Request an Annual Quote

BD Revenues Increase 8 Percent, but Profit Falls on $115M Clontech Charge

NEW YORK, Nov. 4 (GenomeWeb News) - Becton Dickinson today reported that total revenues increased 8 percent in the third quarter to $1.3 billion from $1.2 billion year over year.


Sales at BD's Biosciences unit were flat at $89 million.


BD spent $59 million on research and development in the quarter, up 12 percent from $52 million for the same quarter in 2003.


Net income receded to $67 million for the period from $161 million in the year-ago quarter. The decline reflected a $116 million charge relating to BD's plans to sell its Clontech unit.

BD did not disclose its cash position.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.